OSCR - Company ID 0001568651
The table below shows Oscar Health, Inc.'s income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | $11.70B | $9.18B | $5.86B | $3.96B | $1.84B | $462.80M |
| Cost of revenue | - | - | - | - | - | - |
| Gross profit | - | - | - | - | - | - |
| R&D | - | - | - | - | - | - |
| SG&A | $2.05B |
Oscar Health, Inc. reported annual revenue of $11.70B for fiscal year 2025. That is up 27.5% from $9.18B in fiscal 2024. Over the 7 fiscal years shown, annual revenue grew from $488.19M (FY 2019) to $11.70B. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $1.76B |
| $1.43B |
| $1.26B |
| $265.08M |
| $166.66M |
| Operating income | -$396.36M | $57.27M | -$235.62M | -$589.87M | -$544.48M | -$402.27M |
| Income tax | $5.61M | $7.30M | $3.29M | -$523.00K | $846.00K | $1.04M |
| Net income | -$443.15M | $25.43M | -$270.73M | -$606.27M | -$572.61M | -$406.82M |
| EPS (diluted) | -$1.69 | $0.10 | -$1.22 | -$2.85 | -$3.20 | -$14.16 |